Patients and the referring medical community are choosing HALO Diagnostics because of experts and thought leaders such as Dr. Christopher Hancock.
On November 5, 2022, the Arizona Radiology Society welcomed Halo Diagnostics’ neuroscience physician Dr. Christopher Hancock to share his expertise on the power of multiomics to discover disease. Dr. Hancock is a board-certified diagnostic radiologist in precision medicine at our HALO Diagnostics Innovation Center, specializing in neuroradiology with focused research in dementia, spine pain, regenerative medicine, and wellness/longevity healthcare. Dr. Hancock also teaches as an assistant clinical professor of radiology at University of California, Riverside.
Dr. Hancock was joined at the event by Dr. Alexander Norbash, Dr. Kurt Shoppe, and Dr. Melissa Chen. The group shared their insights into innovative approaches to early detection and its ability to transform the patient experience. Additional topics covered were AI reimbursement and roadmapping the translation future of radiology with a culture of experimentation, design thinking, and servant leadership.
Predictive diagnostics, or personalized medicine, is all about using a patient’s genetic information for early detection of disease or to predict future disease. Multiomics uses artificial intelligence (AI) and machine learning (ML) to pull deeper patient information.
Dr. Hancock’s talk was a deep dive into this innovative science, covering topics including multiomics, diagnostic accuracy and statistical power, dementia diagnostics, and biomarkers of degenerative disease—key subjects of interest for members of the ARS.
What is Multiomics?
Multiomics is an approach in which the data from different “omics” are combined to be analyzed. A recent publication in Nature says, “Omics refers to the measurements of different molecular entities (e.g., transcriptomics, proteomics, epigenomics, etc.), corresponding to various molecular mechanisms (e.g., genetic, epigenetics, etc.) of a single organism or tissue sample.”1
The potential impact multiomics can have on the future of medicine is made clear by Dr. Hancock, who explains, “Multiomics improves diagnostic accuracy and reduces time to diagnosis while also helping physicians find disease before it’s too late.” As explained in the article “Why Multiomics is Healthcare’s Next Big Step,” AI and ML combined with multiomics is an especially powerful way to predict and diagnose complex diseases like dementia.2
The Arizona Radiology Society
The mission of the Arizona Radiology Society (ARS) is to advance the science of radiology, improve radiologic service to the patient, study the socioeconomic aspects of the practice of radiology, and encourage improved and continuing education for radiologists and allied professional fields.3 The input of experts like Dr. Hancock is the kind of knowledge sharing that leads to discovery and improved patient care.
How is HALO Leveraging Multiomics?
HALO Diagnostics is putting multiomics to work using genomics, proteomics, and radiomics (imaging). This advanced approach to personalized care gives doctors a clear picture of a patient’s overall health and empowers patients by making complex information easier to understand.
References
1 Wang, C., Lue, W., Kaalia, R. et al. Network-based integration of multi-omics data for clinical outcome prediction in neuroblastoma. Sci Rep 12, 15425 (2022). https://doi.org/10.1038/s41598-022-19019-5
2 https://www.halodx.com/blog/why-multiomics-is-healthcares-next-big-step/
